Burning Rock Biotech Ltd 20-F filing
Filed 2026-04-28 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001193125-26-183377
- Form type
- 20-F
- CIK
- 0001792267
- Primary document
- https://www.sec.gov/Archives/edgar/data/1792267/000119312526183377/d31568d20f.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Burning Rock Biotech Ltd.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | 539,568,000 | - | - |
| Cost Of Revenue | 136,654,000 | - | - |
| Gross Profit | 402,914,000 | - | - |
| Operating Income | -54,845,000 | - | - |
| Net Income | -55,346,000 | - | - |
| Cash And Equivalents | 478,392,000 | - | - |
| Total Assets | 820,375,000 | - | - |
| Total Liabilities | 285,111,000 | - | - |
| Shareholders Equity | 535,264,000 | - | - |
| Operating Cash Flow | -28,443,000 | - | - |
| Capital Expenditures | 5,249,000 | - | - |